Amikacin (BB-K8) Treatment of Multiple-Drug-Resistant Proteus Infections
Open Access
- 1 May 1974
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 5 (5), 435-438
- https://doi.org/10.1128/aac.5.5.435
Abstract
The new aminoglycoside antibiotic, amikacin (formerly called BB-K8), was used to treat 12 episodes of urinary tract infection caused by hospital-acquired Proteus rettgeri strains. These bacteria were resistant in vitro to kanamycin and gentamicin, and infection persisted in most of the patients in spite of therapy with one of these agents. In all cases, the urinary tract infection was controlled or eradicated by therapy, although relapse or reinfection was frequently encountered in these patients with complicated urological problems. No toxicities attributable to the drug were encountered in the small group of patients.Keywords
This publication has 9 references indexed in Scilit:
- In Vitro Studies of BB-K8, a New Aminoglycoside AntibioticAntimicrobial Agents and Chemotherapy, 1973
- Comparative In Vitro Activity of Three Aminoglycosidic Antibiotics: BB-K8, Kanamycin, and GentamicinAntimicrobial Agents and Chemotherapy, 1973
- Aminoglycoside antibiotics. II. Configurational and positional isomers of BB-K8.1973
- Comparative Pharmacokinetics of BB-K8 and Kanamycin in Dogs and HumansAntimicrobial Agents and Chemotherapy, 1973
- In Vitro Evaluation of a New Aminoglycoside Derivative of Kanamycin, BB-KA: a Comparison with Tobramycin and GentamycinAntimicrobial Agents and Chemotherapy, 1973
- OTOTOXICITY STUDIES WITH BB-K8, A NEW SEMISYNTHETIC AMINOGLYCOSIDE ANTIBIOTICThe Journal of Antibiotics, 1973
- MICROBIOLOGICAL EVALUATION OF BB-K 8, A NEW SEMISYNTHETIC AMINOGLYCOSIDEThe Journal of Antibiotics, 1972
- BB-K8, A NEW SEMISYNTHETIC AMINOGLYCOSIDE ANTIBIOTICThe Journal of Antibiotics, 1972
- Antibiotic susceptibility testing by a standardized single disk method.1966